No shortage on file

APO-DABIGATRAN

APOTEX INC

Quick answers

Is there a shortage of APO-DABIGATRAN in Canada?

No. There is no current shortage of APO-DABIGATRAN 75MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file1 product

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

TEVA-DABIGATRAN

TEVA CANADA LIMITED

75MG · DIN 02463458

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

DIN

02468891

Strength

75MG

Dosage Form

Capsule

Route

Oral

Active Ingredient

DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE)

See all DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244